Overall Technical outlook

Price Summary

GlaxoSmithKline Pharmaceuticals Limited's stock, on 2025-07-16 opened at 3198.0, climbed to a high of 3200.5, dropped to a low of 3153.9, and closed up -0.95% at 3167.6, with 45789 shares traded.
The stock reached its highest price of 3466.2 and lowest price of 1956.2 over the last 52 weeks.
The future price of GLAXO is anticipated to range from 2600.0 to 3500.0, with an expected mean price of 3072.0, according to the recommendations of 4 analysts.

Technicals

Support and Resistance: At 3167.6, the price is supported by 2906.8 and resisted by 3348.2. This indicates that the price for GlaxoSmithKline Pharmaceuticals Limited might fluctuate between these levels, with 2906.8 acting as a support and 3348.2 limiting further upward movement.
GLAXO supportResistance 1d2f4e
Support/Resistance for GLAXO


Aroon: The persistent bearish trend in Aroon, with Aroon Down still at the 100 level, suggests continued weakness. To gain a complete understanding of this trend, it should be explored further in conjunction with other technical indicators.
GLAXO aroon 1d2f4e
Aroon chart for GlaxoSmithKline Pharmaceuticals Limited


Bol. Bands: The current reading of the BOLL BANDS indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
GLAXO bbands 1d2f4e
Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited


Parabolic SAR: The PSAR maintains a bearish outlook, setting a key resistance level that could limit further gains. This resistance reinforces the bearish sentiment, indicating that the market may face challenges in pushing higher.
GLAXO psar 1d2f4e
Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited


Stochastic: The Stochastic K-line for GLAXO is now below the D-line and under 20, reflecting a mildly bearish signal. This suggests that the market could see some downside pressure, but the bearish sentiment is not yet dominant. Traders should be aware of this and monitor the situation closely.
GLAXO stoch 1d2f4e
Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
GLAXO trippleSMA 1d2f4e
Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.